International Women’s Day Spotlight
explains, is to “save lives by pioneering innovative and safe medical devices that enhance patient care, improve outcomes, and make healthcare more accessible.”
Why does diversity matter in the HealthTech landscape? “Diversity is vital to addressing the critical needs of underserved groups, such as women and minorities,” Nathalie continues. She points out that recent data highlights the UK’s significant gender health gap, where women live with ill health or disability three years longer than men on average. “This inequity stems partly from
underinvestment in women’s HealthTech, yet targeted investments can yield remarkable economic and healthcare benefits,” she asserts. Alisa also believes that diversity must be a
core value in HealthTech. She states: “Female professionals bring unique perspectives that drive innovation, particularly in areas like FemTech. Their leadership ensures solutions are inclusive and meet the diverse needs of patients, ultimately improving health outcomes for all.”
How can we encourage the next generation of women in HealthTech? Nathalie points out that to inspire women, we need to amplify the achievements of female leaders, expand access to STEM education, and create scholarships for women: “Removing biases in funding and investment is essential to drive targeted solutions that address women’s health challenges.” Alisa emphasises that encouraging women in HealthTech requires robust networks, support for female-led startups, and a commitment to fostering inclusivity – pointing out that these initiatives will “empower women, strengthen innovation, and enhance the global impact of HealthTech.”
ABHI’s Gender Equality in HealthTech campaign Jane Lewis, ABHI’s Chief Operating Officer, has been at the forefront of initiatives aimed at addressing health inequalities and championing gender equality within the
HealthTech sector. In 2025, ABHI launched its Health Inequalities & Women’s Health Group, a key initiative designed to tackle inequities, particularly in women’s health, and promote equitable access to healthcare. “Our purpose with this group is to act
PARTNER WITH US AND HELP MAKE A DIFFERENCE! March 2025 I
www.clinicalservicesjournal.com 33
as a convener for change,” explains Jane. “By raising awareness of health inequalities and women’s health issues, we aim to create a platform for dialogue, collaboration, and action. It is not just about identifying challenges – it is about empowering our members to be part of the solution. Together, we can amplify these messages and ensure they lead to meaningful change,” she explains. Jane’s leadership in ABHI’s Gender Equality in HealthTech campaign also highlights the importance of representation, data transparency, and systemic improvements across the industry. ABHI’s recent gender equality report captured insights from across the HealthTech sector, revealing key challenges such as balancing work-life commitments, combatting imposter syndrome, and addressing biases in leadership pathways. “The data we gathered underscores the critical
role diversity plays - not just as a moral imperative but as a driver of innovation and economic success,” adds Jane. “By tracking progress annually, we can ensure our industry remains accountable and committed to fostering a culture where everyone, regardless of background, can thrive.” Looking ahead, Jane and ABHI are focused on bridging the gaps in women’s health research, ensuring equitable representation in clinical trials, and addressing barriers that disproportionately affect women in the workplace. “ Representation matters,” Jane concludes. “Together, we have an extraordinary opportunity to lead by example and create a HealthTech sector that truly serves everyone.” For further reading, download ABHI’s
Capturing Gender Equality in HealthTech Report at:
https://www.abhi.org.uk/resource-hub/ file/17714
CSJ
TIME IS OF THE ESSENCE WHEN FIGHTING ANTIMICROBIAL RESISTANCE
bioMérieux provides the most complete solution to support Antimicrobial Stewardship (AMS) initiatives with 80% of our product portfolio dedicated to the fight against AMR.
Our actionable diagnostics paired with complementary advanced analytics, collaborative services and educational modules, enable clinicians to provide earlier, optimised and data-driven therapy for better patient management and a responsible use of antimicrobials.
bioMérieux is the trusted partner that today’s healthcare systems need to confidently deliver evidence-based clinical decisions along the entire patient pathway.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
